Anzeigenschluss: 22.05.2025
Erscheinungstermin: 20.06.2025
Schwerpunkt: Kopf-Hals-Tumoren
J. Moratin
Update Kopf-Hals-Tumoren 2025
A. von Witzleben
Immuntherapie von Kopf-Hals-Tumoren
B. Deschler-Baier
Kopf-Hals-Onkologie des älteren Patienten
Journal Club
Brustkrebs
Hortobagyi GN et al.
A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial
Hodgkin-Lymphom
Federico M et al.
Long-term follow-up of the response-adapted intergroup EORTC/LYSA/FIL H10 trial for localized Hodgkin Lymphoma
Supportivtherapie
Lawrence YR et al.
Celiac plexus radiosurgery for painmanagement in advanced cancer: a multicentre, single-arm, phase 2 trial
NSCLC
Terbuch A et al.
Prognostic impact of targetable driver alterations in resected early-stage lung cancer
Neues aus der Forschung
Brustkrebs
Kuerer HM et al.
Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical Trial
NSCLC
Felip E et al.
Subcutaneous Versus Intravenous Pembrolizumab, in Combination With Chemotherapy, for Treatment of Metastatic Non-Small Cell Lung Cancer: The Phase 3 3475A-D77 Trial
Allgemeine Onkologie
Smith-Bindman R et al.
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging
Hautkrebs
Eggermont CJ
Skin cancer risk in more than 200 000 patients with haematological malignancies over 30 years: a nationwide population-based study in the Netherlands
CME Fortbildung: Gastroonkologie
A. Trojan
Therapie des hepatozellulären Karzinoms
Onkologie aktuell
Kongressbericht 1
10th Heidelberg Myeloma Workshop
Kongressbericht 2
131. Kongress der Deutschen Gesellschaft für Innere Medizin (DGIM)
Kongressbericht 3
The 18th International Congress on Myelodysplastic Syndrome (MDS 2025)
Kongressbericht 4
22nd Annual Cancer Immunotherapy (CIMT) Meeting 2025
Hämatologie
Neues in der Therapie von ITP, AHIA und PNH
*Die Redaktion behält sich aktuelle Änderungen vor.